Related Experiment Video
Updated: Jun 21, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
Published on: September 4, 2017
Evaluating potential benefits of dose-exposure-response modeling for dose finding
1Novartis Pharmaceuticals, East Hanover, NJ 07936, USA. chyihung.hsu@novartis.com
Abstract:
Dose-regimen selection for confirmatory trials and characterization of dose-response relationship are arguably among the most important and difficult tasks in clinical drug development. Inadequate dose-regimen selection is believed to be one of the key drivers of the high attrition rate in Phase III. Nowadays, drug concentrations are routinely measured in patients in clinical studies throughout the drug development process. This drug exposure information is often used to explain some of the response variability. It could also be used to improve characterization of dose-response, and consequently result in a better dose-regimen selection. A simulation study was undertaken to assess the potential value of dose-response characterization methods that utilize exposure data relative to methods that only require dose and response data.
Related Concept Videos
Dose-Response Relationship: Overview
Dose Response Curve: Conventional Versus Nonmonotonic
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
